期刊文献+

OPG和RANKL在创伤后异位骨化模型中的表达及作用

下载PDF
导出
摘要 目的研究创伤后异位骨化模型中护骨素(OPG)和核因子-κB受体活化因子配体(R.ANKL)的表达变化,探讨OPG/RANKL系统在异住骨化发病机制中的作用。方法将30只健康的成年雄性新西兰实验兔随机分为两组:模型组(20只):诱导新西兰实验兔产生异位骨化;对照组(10只),作为空白对照。在造模后第8周处死新西兰实验兔,收集模型组新西兰实验兔形成的异位骨标本作为异位骨化组和对照组实验兔相同部位组织进行对照并行免疫组化染色。结果对照组10只实验兔全部存活至造模后第8周,未发生异位骨化模型组共有18只实验兔存活至造模后第8N,有14只发生异位骨化。异位骨化组异位骨组织中的OPG表达水平明显高于对照组(P〈0.05),异位骨化组异位骨组织中的OPG/RANKL比值明显高于对照组(P〈0.05)。结论OPG/RANKLI比值在异位骨化中增加,可能参与异位骨化的发病发展。 Objective To investigate the expression of OPG and RANKL in the the model of post-traumatic heterotopic ossification and the regulative effects of the OPG/RANKL system on the pathogenesis of formation of heterotopic ossification after trauma. Methods A total of 30 healthy adult male New Zealand laboratorial rabbits were randomly divided into a modeling group (n=20) and a control group (n=10) . Heterotopic ossification was induced in the modeling group. New Zealand laboratorial rabbits in the control group were not established model of heterotopic ossification. All animals were sacrificed at the end of 8 weeks. Ectopic bone specimens from New Zealand laboratorial rabbits in the modeling group and normal tissue from New Zealand laboratorial rabbits in the control group was harvested and stained immunohistochemically to detect OPG and RANKL expression. Results None of the 10 New Zealand white rabbits in the control group showed heterotopic ossification. A total of 18 New Zealand laboratorial rabbits in the modeling group survived after eight weeks and 14 showed heterotopic ossification. The level of OPG expression in ectopic bone specimens was significantly higher in the modeling group than in the control group ( P〈0.05 ) .The OPG and RANKL expression ratio in ectopic bone specimens was also significantly higher in the modeling group than in the control group ( P〈0.05 ) . Conelusion OPG/RANKL system may play a regulative role in the development ofheterotopic ossification. The increased OPG to RANKL ratio may be related to the formation ofheterotopic ossification.
出处 《浙江临床医学》 2018年第4期638-639,642,共3页 Zhejiang Clinical Medical Journal
基金 浙江省医药卫生研究计划项目(2016KYB291)
关键词 异位骨化 护骨素 核因子-ΚB受体活化因子配体 Heterotopic ossification OPG RANKL
  • 相关文献

参考文献1

二级参考文献18

  • 1Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther,2007,9 Supp| 1 :S1.
  • 2Wright HL, McCarthy HS, Middleton J, et al. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med ,2009,2( 1 ) :56-64.
  • 3LeeSH,Rho J, Jeong D, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med ,2006,12 ( 12 ) : 1403-1409.
  • 4Perez-Amodio S, Beertsen W, Everts V. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclastsl. J Bone Miner Res,200d,19(10) :1722-17231.
  • 5Ehnert S, Baur J, Schmitt A, et al. TGF-[3 ( 1 ) As Possible Link between Loss of Bone Mineral Density and Chronic Inflammation. PLoS One,2010,5( 11 ) :e14073.
  • 6Jules J,Shi Z, Liu J, et al. Receptor Activator of NF- I kappa t B (RANK) Cytoplasmic IVVY535-538 Motif Plays an Essential Role in Tumor Necrosis Factor-{ alpha t ( TNF )-medlated Osteoclastogenesis. J Biol Chem,2010,285 (48) : 37427-37435.
  • 7Boyan BD,Schwartz Z, Lohmann CH. et al. Pretreatment of bone with osteoclasts affects phenotypic expression of osteoblast-like cells. J Orthop Res,2003,21 (4) :638-647.
  • 8Sanchez-Fernandez MA, Gallois A, Riedl T, et al. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling. PLoS One, 2008,3 ( 10 ) : e3537.
  • 9Kubota K, Sakikawa C, Katsumata M, et al. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor. J Bone Miner Res, 2002,17 (2) :257-265.
  • 10YasudaH. Bone and bone related biochemical examinations. Bone and collagen related metabolites. Receptor activator of NF-kappaB ligaad (RANKL) . Clin Calcium ,2006,16 (6) :964-970.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部